161 related articles for article (PubMed ID: 35671435)
1. Current Systemic Treatments for the Hereditary Cancer Syndromes: Drug Development in Light of Genomic Defects.
Hasanov E; Pimentel I; Cruellas M; Lewis MA; Jonasch E; Balmaña J
Am Soc Clin Oncol Educ Book; 2022 Apr; 42():1-17. PubMed ID: 35671435
[TBL] [Abstract][Full Text] [Related]
2. Hemangioblastoma in Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome: a phenotypic overlap between VHL and HLRCC Syndromes.
Dow E; Winship IM
Fam Cancer; 2019 Jan; 18(1):91-95. PubMed ID: 29619618
[TBL] [Abstract][Full Text] [Related]
3. Von Hippel Lindau syndrome.
Kim JJ; Rini BI; Hansel DE
Adv Exp Med Biol; 2010; 685():228-49. PubMed ID: 20687511
[TBL] [Abstract][Full Text] [Related]
4. von Hippel-Lindau disease: recent advances and therapeutic perspectives.
Richard S;
Expert Rev Anticancer Ther; 2003 Apr; 3(2):215-33. PubMed ID: 12722881
[TBL] [Abstract][Full Text] [Related]
5. Endolymphatic sac tumors in patients with and without von Hippel-Lindau disease: the role of genetic mutation, von Hippel-Lindau protein, and hypoxia inducible factor-1alpha expression.
Jensen RL; Gillespie D; House P; Layfield L; Shelton C
J Neurosurg; 2004 Mar; 100(3):488-97. PubMed ID: 15035285
[TBL] [Abstract][Full Text] [Related]
6. The pathological and molecular genetic landscape of the hereditary renal cancer predisposition syndromes.
Al-Obaidy KI; Alruwaii ZI; Williamson SR; Cheng L
Histopathology; 2022 Jul; 81(1):15-31. PubMed ID: 35315118
[TBL] [Abstract][Full Text] [Related]
7. [Von Hippel-Lindau disease: recent advances in genetics and clinical management].
Richard S; Parker F; Aghakhani N; Allegre G; Portier F; David P; Marsot-Dupuch K
J Neuroradiol; 2005 Jun; 32(3):157-67. PubMed ID: 16134297
[TBL] [Abstract][Full Text] [Related]
8. Germ-line mutations in the von Hippel-Lindau tumor-suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma.
Whaley JM; Naglich J; Gelbert L; Hsia YE; Lamiell JM; Green JS; Collins D; Neumann HP; Laidlaw J; Li FP
Am J Hum Genet; 1994 Dec; 55(6):1092-102. PubMed ID: 7977367
[TBL] [Abstract][Full Text] [Related]
9. The Endothelial Landscape and Its Role in Von Hippel-Lindau Disease.
de Rojas-P I; Albiñana V; Taranets L; Recio-Poveda L; Cuesta AM; Popov N; Kronenberger T; Botella LM
Cells; 2021 Sep; 10(9):. PubMed ID: 34571962
[TBL] [Abstract][Full Text] [Related]
10. Neurofibromatosis type 2 and von Hippel-Lindau disease: from gene cloning to function.
Kley N; Whaley J; Seizinger BR
Glia; 1995 Nov; 15(3):297-307. PubMed ID: 8586465
[TBL] [Abstract][Full Text] [Related]
11. Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidney.
Beroukhim R; Brunet JP; Di Napoli A; Mertz KD; Seeley A; Pires MM; Linhart D; Worrell RA; Moch H; Rubin MA; Sellers WR; Meyerson M; Linehan WM; Kaelin WG; Signoretti S
Cancer Res; 2009 Jun; 69(11):4674-81. PubMed ID: 19470766
[TBL] [Abstract][Full Text] [Related]
12. De novo VHL germline mutation detected in a patient with mild clinical phenotype of von Hippel-Lindau disease.
Ding X; Zhang C; Frerich JM; Germanwala A; Yang C; Lonser RR; Mao Y; Zhuang Z; Zhang M
J Neurosurg; 2014 Aug; 121(2):384-386. PubMed ID: 24678776
[TBL] [Abstract][Full Text] [Related]
13. Integrative analysis of dysregulated microRNAs and mRNAs in multiple recurrent synchronized renal tumors from patients with von Hippel-Lindau disease.
Gattolliat CH; Couvé S; Meurice G; Oréar C; Droin N; Chiquet M; Ferlicot S; Verkarre V; Vasiliu V; Molinié V; Méjean A; Dessen P; Giraud S; Bressac-De-Paillerets B; Gardie B; Tean Teh B; Richard S; Gad S
Int J Oncol; 2018 Oct; 53(4):1455-1468. PubMed ID: 30066860
[TBL] [Abstract][Full Text] [Related]
14. Von Hippel-Lindau: how a rare disease illuminates cancer biology.
Richard S; Gardie B; Couvé S; Gad S
Semin Cancer Biol; 2013 Feb; 23(1):26-37. PubMed ID: 22659535
[TBL] [Abstract][Full Text] [Related]
15. [Von Hippel-Lindau disease: recent genetic progress and patient management. Francophone Study Group of von Hippel-Lindau Disease (GEFVH)].
Richard S; Giraud S; Beroud C; Caron J; Penfornis F; Baudin E; Niccoli-Sire P; Murat A; Schlumberger M; Plouin PF; Conte-Devolx B
Ann Endocrinol (Paris); 1998; 59(6):452-8. PubMed ID: 10189987
[TBL] [Abstract][Full Text] [Related]
16. Cytogenetic and fluorescence in situ hybridization studies on sporadic and hereditary tumors associated with von Hippel-Lindau syndrome (VHL).
Decker HJ; Klauck SM; Lawrence JB; McNeil J; Smith D; Gemmill RM; Sandberg AA; Neumann HH; Simon B; Green J
Cancer Genet Cytogenet; 1994 Oct; 77(1):1-13. PubMed ID: 7923076
[TBL] [Abstract][Full Text] [Related]
17. The impact of molecular genetic analysis of the VHL gene in patients with haemangioblastomas of the central nervous system.
Gläsker S; Bender BU; Apel TW; Natt E; van Velthoven V; Scheremet R; Zentner J; Neumann HP
J Neurol Neurosurg Psychiatry; 1999 Dec; 67(6):758-62. PubMed ID: 10567493
[TBL] [Abstract][Full Text] [Related]
18. Hereditary renal cell carcinoma syndromes: diagnosis, surveillance and management.
Maher ER
World J Urol; 2018 Dec; 36(12):1891-1898. PubMed ID: 29680948
[TBL] [Abstract][Full Text] [Related]
19. Von Hippel-Lindau disease: clinical and molecular perspectives.
Clifford SC; Maher ER
Adv Cancer Res; 2001; 82():85-105. PubMed ID: 11447766
[TBL] [Abstract][Full Text] [Related]
20. Genotype and phenotype correlation in von Hippel-Lindau disease based on alteration of the HIF-α binding site in VHL protein.
Liu SJ; Wang JY; Peng SH; Li T; Ning XH; Hong BA; Liu JY; Wu PJ; Zhou BW; Zhou JC; Qi NN; Peng X; Zhang JF; Ma KF; Cai L; Gong K
Genet Med; 2018 Oct; 20(10):1266-1273. PubMed ID: 29595810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]